Fairvalue-Calculator Fairvalue-Calculator
EN DE

Trajan Group (TRJ) Fair Value & Analysis

Healthcare · AU · Market cap A$48.2M

PriceA$0.2300
Fair ValueA$0.1000
Upside-56.5%
Quality95/100
Evidence: High Range A$0.1000 – A$0.2000

Fair value as of: Jun 25, 2026

Analysis

Trajan Group (TRJ) currently trades at A$0.2300, while our model-based Fair Value estimate is A$0.1000 — implying the stock looks roughly 56.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Trajan Group Holdings Limited develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, inlet liners, rings, and tubing products; and sampling products, comprising septa, caps, liners, well plates and sealing mats, crimping tools, and micro sampling tools, as well as automation systems and consumables. It also provides pathology products, consisting of NBF containers, adhesive and frosted microscope slides, coverslips, microtome blades, biopsy pads, microscope slide storage trays/mailers, microscope slide and cassette storage boxes, histology wax plus, and tissue marking dyes and sets, and MiPlatform, a smartphone adapter; on-line and laboratory instruments and related parts and services; and miniaturized and portable instrumentation, as well as products and services relat…

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -61% EssilorLuxottica Société anonyme (ESLOF) -34% HOYA Corporation (HOCPY) -38% Medline Inc (MDLN) -5% Becton, Dickinson and Company (BDX) -16% Alcon Inc (ALC) -44%

Frequently asked questions

Is Trajan Group (TRJ) undervalued?
As of Jun 25, 2026, our model estimates a fair value of A$0.1000 versus a price of A$0.2300 — about −57% (overvalued). Model-based estimate, not financial advice.
What is the fair value of TRJ?
Our 21-model fair value for Trajan Group is A$0.1000 (as of Jun 25, 2026), built from audited fundamentals. The current price is A$0.2300.
What is the quality score of TRJ?
Trajan Group has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.